Kevin Woolston
5 Papers
Kevin Woolston is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections
Henry M. Staines,Daniela E. Kirwan,David J Clark,Emily R. Adams,Yolanda Augustin,Rachel L Byrne,Michael Cocozza,Ana I Cubas-Atienza,Luis E. Cuevas,Martina Cusinato,Benedict M O Davies,Mark M. Davis,Paul A. Davis,Annelyse Duvoix,Nicholas M Eckersley,Daniel M. Forton,Alice J. Fraser,Gala Garrod,Linda Hadcocks,Qinxue Hu,Michael H. Johnson,Grant A Kay,Kesja Klekotko,Zawditu Lewis,Josephine Mensah-Kane,Stefanie Menzies,Irene M. Monahan,Catherine M. Moore,Gerhard Nebe-von-Caron,Sophie I Owen,Chris Sainter,Amadou A. Sall,James Schouten,Christopher T Williams,John T. Wilkins,Kevin Woolston,Joseph R Fitchett,Sanjeev Krishna,Tim Planche +38 more
TL;DR: Dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in 177 individuals diagnosed by RT-PCR are reported and higher antibody responses are associated with symptomatic disease, older age, ethnicity, increased co-morbidity and higher inflammatory markers such as C Reactive Protein.
Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration
Emily R. Adams,Yolanda Augustin,Rachel L Byrne,David J Clark,Michael Cocozza,Ana I Cubas-Atienzar,Luis E. Cuevas,Martina Cusinato,Benedict M O Davies,Mark S. Davies,Paul Davies,Annelyse Duvoix,Nicholas M Eckersley,Thomas Edwards,Tom Fletcher,Alice J. Fraser,Gala Garrod,Linda Hadcocks,Qinxue Hu,Michael H. Johnson,Grant A Kay,Katherin Keymer,Daniela E. Kirwan,Kesja Klekotko,Zawditu Lewis,Jenifer C. Mason,Josie Mensah-Kane,Stefanie Menzies,Irene M. Monahan,Catherine M. Moore,Gerhard Nebe-von-Caron,Sophie I Owen,Tim Planche,Chris Sainter,James Schouten,Henry M. Staines,Lance Turtle,Lance Turtle,Christopher T Williams,John T. Wilkins,Kevin Woolston,Amadou A. Sall,Joseph R Fitchett,Sanjeev Krishna +43 more
TL;DR: This is the first in a series of Mologic products for CO VID-19, which will be deployed for COVID-19 diagnosis, contact tracing and sero-epidemiological studies to estimate disease burden and transmission with a focus on ensuring access, affordability, and availability to lowest resource settings.
•Journal Article
Inflammatory biomarkers in urine of cystic fibrosis patients
Gita Parekh,Michael M. Tunney,Emilie Vallières,Stef J. McGrath,L. McIlreavey,E. Johnston,Damian G. Downey,Kevin Woolston,Paul A. Davis,Stuart Elborn +9 more
TL;DR: Markers can be detected and quantified in urine and whether changes in levels of any of these can be used to predict exacerbation onset in order to instigate pre-emptive therapy is investigated.
2
Laboratory Evaluation and Field Testing of Dengue NS1 and IgM/IgG Rapid Diagnostic Tests in an Epidemic Context in Senegal
Oumar Ndiaye,Kevin Woolston,Abou Beckr Gaye,Cheikh Loucoubar,Michael Cocozza,Cheikh Fall,Fatou Dia,Emily R. Adams,Marieme Samb,Diogop Camara,Bacary D. Sadio,Cheikh Tidiane Diagne,Manfred Weidmann,Oumar Faye,Joseph R A Fitchett,Amadou A. Sall +15 more
TL;DR: In this paper , the authors evaluated the diagnostic performance of the Dengue NS1 and Dengue IgM/IgG RDTs on the serum/plasma samples in a laboratory setting and in the field.
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Henry M. Staines,Daniela E. Kirwan,David J. Clark,Emily R. Adams,Yolanda Augustin,Rachel L Byrne,Michael Cocozza,Ana I Cubas-Atienzar,Luis E. Cuevas,Martina Cusinato,Benedict M O Davies,Mark M. Davis,Paul A. Davis,Annelyse Duvoix,Nicholas M Eckersley,Daniel M. Forton,Alice J. Fraser,Gala Garrod,Linda Hadcocks,Qinxue Hu,Michael H. Johnson,Grant A Kay,Kesja Klekotko,Zawditu Lewis,Derek C. Macallan,Josephine Mensah-Kane,Stefanie Menzies,Irene M. Monahan,Catherine Moore,Gerhard Nebe-von-Caron,Sophie I Owen,Chris Sainter,Amadou A. Sall,James Schouten,Christopher T Williams,John T. Wilkins,Kevin Woolston,Joseph R Fitchett,Sanjeev Krishna,Tim Planche +39 more
TL;DR: It was found that 2.0%–8.5% of persons did not seroconvert 3–6 weeks after infection, and non-White persons had higher antibody concentrations than those who identified as White; these concentrations did not decline during follow-up.